Selected research
Market Analysis & Forecast
Global Anti-PD-1 Antibody Market Analysis and Forecast 2026-2032
Market perspective
The global Anti-PD-1 Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Anti-PD-1 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Anti-PD-1 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Anti-PD-1 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Anti-PD-1 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Anti-PD-1 Antibody include 3SBio Inc, Thermo Fisher, Novartis, Merck, Lilly, Sino Biological Inc, Bristol-Myers Squibb (BMS), Abcam and Abbvie, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Anti-PD-1 Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Anti-PD-1 Antibody, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-PD-1 Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-PD-1 Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-PD-1 Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti-PD-1 Antibody sales, projected growth trends, production technology, application and end-user industry.
Anti-PD-1 Antibody Segment by Company
3SBio Inc
Thermo Fisher
Novartis
Merck
Lilly
Sino Biological Inc
Bristol-Myers Squibb (BMS)
Abcam
Abbvie
TG Therapeutics, Inc
Ono Pharmaceutical Co., Ltd
InvivoGen
Chugai Pharmaceutical Co., Ltd
BioVision Inc
Bio X Cell
BeiGene
Arcus Biosciences
Anti-PD-1 Antibody Segment by Type
Monoclonal
Polyclonal
Anti-PD-1 Antibody Segment by Application
IHC-P
ICC/IF
ELISA
Flow Cytometry
WB
Anti-PD-1 Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-PD-1 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-PD-1 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-PD-1 Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Anti-PD-1 Antibody in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Anti-PD-1 Antibody manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-PD-1 Antibody sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Anti-PD-1 Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Table 2. Monoclonal Major Manufacturers
Table 3. Polyclonal Major Manufacturers
Table 4. Global Anti-PD-1 Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Table 5. IHC-P Major Manufacturers
Table 6. ICC/IF Major Manufacturers
Table 7. ELISA Major Manufacturers
Table 8. Flow Cytometry Major Manufacturers
Table 9. WB Major Manufacturers
Table 10. Anti-PD-1 Antibody Industry Trends
Table 11. Anti-PD-1 Antibody Industry Drivers
Table 12. Anti-PD-1 Antibody Industry Opportunities and Challenges
Table 13. Anti-PD-1 Antibody Industry Restraints
Table 14. Global Anti-PD-1 Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 15. Global Anti-PD-1 Antibody Revenue by Region (2021-2026) & (US$ Million)
Table 16. Global Anti-PD-1 Antibody Revenue by Region (2027-2032) & (US$ Million)
Table 17. Global Anti-PD-1 Antibody Revenue Market Share by Region (2021-2026)
Table 18. Global Anti-PD-1 Antibody Revenue Market Share by Region (2027-2032)
Table 19. Global Anti-PD-1 Antibody Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg)
Table 20. Global Anti-PD-1 Antibody Sales by Region (2021-2026) & (kg)
Table 21. Global Anti-PD-1 Antibody Sales by Region (2027-2032) & (kg)
Table 22. Global Anti-PD-1 Antibody Sales Market Share by Region (2021-2026)
Table 23. Global Anti-PD-1 Antibody Sales Market Share by Region (2027-2032)
Table 24. Global Anti-PD-1 Antibody Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 25. Global Anti-PD-1 Antibody Revenue Market Share by Manufacturers (2021-2026)
Table 26. Global Anti-PD-1 Antibody Sales by Manufacturers (US$ Million) & (2021-2026)
Table 27. Global Anti-PD-1 Antibody Sales Market Share by Manufacturers (2021-2026)
Table 28. Global Anti-PD-1 Antibody Sales Price (US$/g) of Manufacturers (2021-2026)
Table 29. Global Anti-PD-1 Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 30. Global Anti-PD-1 Antibody Key Manufacturers Manufacturing Sites & Headquarters
Table 31. Global Anti-PD-1 Antibody Manufacturers, Product Type & Application
Table 32. Global Anti-PD-1 Antibody Manufacturers' Establishment Date
Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Anti-PD-1 Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 35. Global Anti-PD-1 Antibody Revenue by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 36. Global Anti-PD-1 Antibody Revenue by Type (2021-2026) & (US$ Million)
Table 37. Global Anti-PD-1 Antibody Revenue by Type (2027-2032) & (US$ Million)
Table 38. Global Anti-PD-1 Antibody Revenue Market Share by Type (2021-2026)
Table 39. Global Anti-PD-1 Antibody Revenue Market Share by Type (2027-2032)
Table 40. Global Anti-PD-1 Antibody Sales by Type 2021 VS 2025 VS 2032 (kg)
Table 41. Global Anti-PD-1 Antibody Sales by Type (2021-2026) & (kg)
Table 42. Global Anti-PD-1 Antibody Sales by Type (2027-2032) & (kg)
Table 43. Global Anti-PD-1 Antibody Sales Market Share by Type (2021-2026)
Table 44. Global Anti-PD-1 Antibody Sales Market Share by Type (2027-2032)
Table 45. Global Anti-PD-1 Antibody Price by Type (2021-2026) & (US$/g)
Table 46. Global Anti-PD-1 Antibody Price by Type (2027-2032) & (US$/g)
Table 47. Global Anti-PD-1 Antibody Revenue by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 48. Global Anti-PD-1 Antibody Revenue by Application (2021-2026) & (US$ Million)
Table 49. Global Anti-PD-1 Antibody Revenue by Application (2027-2032) & (US$ Million)
Table 50. Global Anti-PD-1 Antibody Revenue Market Share by Application (2021-2026)
Table 51. Global Anti-PD-1 Antibody Revenue Market Share by Application (2027-2032)
Table 52. Global Anti-PD-1 Antibody Sales by Application 2021 VS 2025 VS 2032 (kg)
Table 53. Global Anti-PD-1 Antibody Sales by Application (2021-2026) & (kg)
Table 54. Global Anti-PD-1 Antibody Sales by Application (2027-2032) & (kg)
Table 55. Global Anti-PD-1 Antibody Sales Market Share by Application (2021-2026)
Table 56. Global Anti-PD-1 Antibody Sales Market Share by Application (2027-2032)
Table 57. Global Anti-PD-1 Antibody Price by Application (2021-2026) & (US$/g)
Table 58. Global Anti-PD-1 Antibody Price by Application (2027-2032) & (US$/g)
Table 59. 3SBio Inc Company Information
Table 60. 3SBio Inc Business Overview
Table 61. 3SBio Inc Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 62. 3SBio Inc Anti-PD-1 Antibody Product Portfolio
Table 63. 3SBio Inc Recent Development
Table 64. Thermo Fisher Company Information
Table 65. Thermo Fisher Business Overview
Table 66. Thermo Fisher Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 67. Thermo Fisher Anti-PD-1 Antibody Product Portfolio
Table 68. Thermo Fisher Recent Development
Table 69. Novartis Company Information
Table 70. Novartis Business Overview
Table 71. Novartis Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 72. Novartis Anti-PD-1 Antibody Product Portfolio
Table 73. Novartis Recent Development
Table 74. Merck Company Information
Table 75. Merck Business Overview
Table 76. Merck Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 77. Merck Anti-PD-1 Antibody Product Portfolio
Table 78. Merck Recent Development
Table 79. Lilly Company Information
Table 80. Lilly Business Overview
Table 81. Lilly Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 82. Lilly Anti-PD-1 Antibody Product Portfolio
Table 83. Lilly Recent Development
Table 84. Sino Biological Inc Company Information
Table 85. Sino Biological Inc Business Overview
Table 86. Sino Biological Inc Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 87. Sino Biological Inc Anti-PD-1 Antibody Product Portfolio
Table 88. Sino Biological Inc Recent Development
Table 89. Bristol-Myers Squibb (BMS) Company Information
Table 90. Bristol-Myers Squibb (BMS) Business Overview
Table 91. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 92. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Portfolio
Table 93. Bristol-Myers Squibb (BMS) Recent Development
Table 94. Abcam Company Information
Table 95. Abcam Business Overview
Table 96. Abcam Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 97. Abcam Anti-PD-1 Antibody Product Portfolio
Table 98. Abcam Recent Development
Table 99. Abbvie Company Information
Table 100. Abbvie Business Overview
Table 101. Abbvie Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 102. Abbvie Anti-PD-1 Antibody Product Portfolio
Table 103. Abbvie Recent Development
Table 104. TG Therapeutics, Inc Company Information
Table 105. TG Therapeutics, Inc Business Overview
Table 106. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 107. TG Therapeutics, Inc Anti-PD-1 Antibody Product Portfolio
Table 108. TG Therapeutics, Inc Recent Development
Table 109. Ono Pharmaceutical Co., Ltd Company Information
Table 110. Ono Pharmaceutical Co., Ltd Business Overview
Table 111. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 112. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
Table 113. Ono Pharmaceutical Co., Ltd Recent Development
Table 114. InvivoGen Company Information
Table 115. InvivoGen Business Overview
Table 116. InvivoGen Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 117. InvivoGen Anti-PD-1 Antibody Product Portfolio
Table 118. InvivoGen Recent Development
Table 119. Chugai Pharmaceutical Co., Ltd Company Information
Table 120. Chugai Pharmaceutical Co., Ltd Business Overview
Table 121. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 122. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
Table 123. Chugai Pharmaceutical Co., Ltd Recent Development
Table 124. BioVision Inc Company Information
Table 125. BioVision Inc Business Overview
Table 126. BioVision Inc Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 127. BioVision Inc Anti-PD-1 Antibody Product Portfolio
Table 128. BioVision Inc Recent Development
Table 129. Bio X Cell Company Information
Table 130. Bio X Cell Business Overview
Table 131. Bio X Cell Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 132. Bio X Cell Anti-PD-1 Antibody Product Portfolio
Table 133. Bio X Cell Recent Development
Table 134. BeiGene Company Information
Table 135. BeiGene Business Overview
Table 136. BeiGene Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 137. BeiGene Anti-PD-1 Antibody Product Portfolio
Table 138. BeiGene Recent Development
Table 139. Arcus Biosciences Company Information
Table 140. Arcus Biosciences Business Overview
Table 141. Arcus Biosciences Anti-PD-1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 142. Arcus Biosciences Anti-PD-1 Antibody Product Portfolio
Table 143. Arcus Biosciences Recent Development
Table 144. North America Anti-PD-1 Antibody Revenue by Type (2021-2026) & (US$ Million)
Table 145. North America Anti-PD-1 Antibody Revenue by Type (2027-2032) & (US$ Million)
Table 146. North America Anti-PD-1 Antibody Sales by Type (2021-2026) & (kg)
Table 147. North America Anti-PD-1 Antibody Sales by Type (2027-2032) & (kg)
Table 148. North America Anti-PD-1 Antibody Sales Price by Type (2021-2026) & (US$/g)
Table 149. North America Anti-PD-1 Antibody Sales Price by Type (2027-2032) & (US$/g)
Table 150. North America Anti-PD-1 Antibody Revenue by Application (2021-2026) & (US$ Million)
Table 151. North America Anti-PD-1 Antibody Revenue by Application (2027-2032) & (US$ Million)
Table 152. North America Anti-PD-1 Antibody Sales by Application (2021-2026) & (kg)
Table 153. North America Anti-PD-1 Antibody Sales by Application (2027-2032) & (kg)
Table 154. North America Anti-PD-1 Antibody Sales Price by Application (2021-2026) & (US$/g)
Table 155. North America Anti-PD-1 Antibody Sales Price by Application (2027-2032) & (US$/g)
Table 156. North America Anti-PD-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 157. North America Anti-PD-1 Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million)
Table 158. North America Anti-PD-1 Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million)
Table 159. North America Anti-PD-1 Antibody Sales by Country (2021 VS 2025 VS 2032) & (kg)
Table 160. North America Anti-PD-1 Antibody Sales by Country (2021-2026) & (kg)
Table 161. North America Anti-PD-1 Antibody Sales by Country (2027-2032) & (kg)
Table 162. North America Anti-PD-1 Antibody Sales Price by Country (2021-2026) & (US$/g)
Table 163. North America Anti-PD-1 Antibody Sales Price by Country (2027-2032) & (US$/g)
Table 164. United States Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 165. Canada Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 166. Mexico Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 167. Europe Anti-PD-1 Antibody Revenue by Type (2021-2026) & (US$ Million)
Table 168. Europe Anti-PD-1 Antibody Revenue by Type (2027-2032) & (US$ Million)
Table 169. Europe Anti-PD-1 Antibody Sales by Type (2021-2026) & (kg)
Table 170. Europe Anti-PD-1 Antibody Sales by Type (2027-2032) & (kg)
Table 171. Europe Anti-PD-1 Antibody Sales Price by Type (2021-2026) & (US$/g)
Table 172. Europe Anti-PD-1 Antibody Sales Price by Type (2027-2032) & (US$/g)
Table 173. Europe Anti-PD-1 Antibody Revenue by Application (2021-2026) & (US$ Million)
Table 174. Europe Anti-PD-1 Antibody Revenue by Application (2027-2032) & (US$ Million)
Table 175. Europe Anti-PD-1 Antibody Sales by Application (2021-2026) & (kg)
Table 176. Europe Anti-PD-1 Antibody Sales by Application (2027-2032) & (kg)
Table 177. Europe Anti-PD-1 Antibody Sales Price by Application (2021-2026) & (US$/g)
Table 178. Europe Anti-PD-1 Antibody Sales Price by Application (2027-2032) & (US$/g)
Table 179. Europe Anti-PD-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 180. Europe Anti-PD-1 Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million)
Table 181. Europe Anti-PD-1 Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million)
Table 182. Europe Anti-PD-1 Antibody Sales by Country (2021 VS 2025 VS 2032) & (kg)
Table 183. Europe Anti-PD-1 Antibody Sales by Country (2021-2026) & (kg)
Table 184. Europe Anti-PD-1 Antibody Sales by Country (2027-2032) & (kg)
Table 185. Europe Anti-PD-1 Antibody Sales Price by Country (2021-2026) & (US$/g)
Table 186. Europe Anti-PD-1 Antibody Sales Price by Country (2027-2032) & (US$/g)
Table 187. Germany Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 188. France Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 189. U.K. Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 190. Italy Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 191. Russia Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 192. Spain Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 193. Netherlands Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 194. Switzerland Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 195. Sweden Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 196. Poland Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 197. China Anti-PD-1 Antibody Revenue by Type (2021-2026) & (US$ Million)
Table 198. China Anti-PD-1 Antibody Revenue by Type (2027-2032) & (US$ Million)
Table 199. China Anti-PD-1 Antibody Sales by Type (2021-2026) & (kg)
Table 200. China Anti-PD-1 Antibody Sales by Type (2027-2032) & (kg)
Table 201. China Anti-PD-1 Antibody Sales Price by Type (2021-2026) & (US$/g)
Table 202. China Anti-PD-1 Antibody Sales Price by Type (2027-2032) & (US$/g)
Table 203. China Anti-PD-1 Antibody Revenue by Application (2021-2026) & (US$ Million)
Table 204. China Anti-PD-1 Antibody Revenue by Application (2027-2032) & (US$ Million)
Table 205. China Anti-PD-1 Antibody Sales by Application (2021-2026) & (kg)
Table 206. China Anti-PD-1 Antibody Sales by Application (2027-2032) & (kg)
Table 207. China Anti-PD-1 Antibody Sales Price by Application (2021-2026) & (US$/g)
Table 208. China Anti-PD-1 Antibody Sales Price by Application (2027-2032) & (US$/g)
Table 209. Asia Anti-PD-1 Antibody Revenue by Type (2021-2026) & (US$ Million)
Table 210. Asia Anti-PD-1 Antibody Revenue by Type (2027-2032) & (US$ Million)
Table 211. Asia Anti-PD-1 Antibody Sales by Type (2021-2026) & (kg)
Table 212. Asia Anti-PD-1 Antibody Sales by Type (2027-2032) & (kg)
Table 213. Asia Anti-PD-1 Antibody Sales Price by Type (2021-2026) & (US$/g)
Table 214. Asia Anti-PD-1 Antibody Sales Price by Type (2027-2032) & (US$/g)
Table 215. Asia Anti-PD-1 Antibody Revenue by Application (2021-2026) & (US$ Million)
Table 216. Asia Anti-PD-1 Antibody Revenue by Application (2027-2032) & (US$ Million)
Table 217. Asia Anti-PD-1 Antibody Sales by Application (2021-2026) & (kg)
Table 218. Asia Anti-PD-1 Antibody Sales by Application (2027-2032) & (kg)
Table 219. Asia Anti-PD-1 Antibody Sales Price by Application (2021-2026) & (US$/g)
Table 220. Asia Anti-PD-1 Antibody Sales Price by Application (2027-2032) & (US$/g)
Table 221. Asia Anti-PD-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 222. Asia Anti-PD-1 Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million)
Table 223. Asia Anti-PD-1 Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million)
Table 224. Asia Anti-PD-1 Antibody Sales by Country (2021 VS 2025 VS 2032) & (kg)
Table 225. Asia Anti-PD-1 Antibody Sales by Country (2021-2026) & (kg)
Table 226. Asia Anti-PD-1 Antibody Sales by Country (2027-2032) & (kg)
Table 227. Asia Anti-PD-1 Antibody Sales Price by Country (2021-2026) & (US$/g)
Table 228. Asia Anti-PD-1 Antibody Sales Price by Country (2027-2032) & (US$/g)
Table 229. Japan Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 230. South Korea Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 231. India Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 232. Australia Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 233. Taiwan Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 234. Southeast Asia Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 235. SAMEA Anti-PD-1 Antibody Revenue by Type (2021-2026) & (US$ Million)
Table 236. SAMEA Anti-PD-1 Antibody Revenue by Type (2027-2032) & (US$ Million)
Table 237. SAMEA Anti-PD-1 Antibody Sales by Type (2021-2026) & (kg)
Table 238. SAMEA Anti-PD-1 Antibody Sales by Type (2027-2032) & (kg)
Table 239. SAMEA Anti-PD-1 Antibody Sales Price by Type (2021-2026) & (US$/g)
Table 240. SAMEA Anti-PD-1 Antibody Sales Price by Type (2027-2032) & (US$/g)
Table 241. SAMEA Anti-PD-1 Antibody Revenue by Application (2021-2026) & (US$ Million)
Table 242. SAMEA Anti-PD-1 Antibody Revenue by Application (2027-2032) & (US$ Million)
Table 243. SAMEA Anti-PD-1 Antibody Sales by Application (2021-2026) & (kg)
Table 244. SAMEA Anti-PD-1 Antibody Sales by Application (2027-2032) & (kg)
Table 245. SAMEA Anti-PD-1 Antibody Sales Price by Application (2021-2026) & (US$/g)
Table 246. SAMEA Anti-PD-1 Antibody Sales Price by Application (2027-2032) & (US$/g)
Table 247. SAMEA Anti-PD-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 248. SAMEA Anti-PD-1 Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million)
Table 249. SAMEA Anti-PD-1 Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million)
Table 250. SAMEA Anti-PD-1 Antibody Sales by Country (2021 VS 2025 VS 2032) & (kg)
Table 251. SAMEA Anti-PD-1 Antibody Sales by Country (2021-2026) & (kg)
Table 252. SAMEA Anti-PD-1 Antibody Sales by Country (2027-2032) & (kg)
Table 253. SAMEA Anti-PD-1 Antibody Sales Price by Country (2021-2026) & (US$/g)
Table 254. SAMEA Anti-PD-1 Antibody Sales Price by Country (2027-2032) & (US$/g)
Table 255. Brazil Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 256. Argentina Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 257. Chile Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 258. Colombia Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 259. Peru Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 260. Saudi Arabia Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 261. Israel Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 262. UAE Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 263. Turkey Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 264. Iran Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 265. Egypt Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Table 266. Key Raw Materials
Table 267. Raw Materials Key Suppliers
Table 268. Anti-PD-1 Antibody Distributors List
Table 269. Anti-PD-1 Antibody Customers List
Table 270. Research Programs/Design for This Report
Table 271. Authors List of This Report
Table 272. Secondary Sources
Table 273. Primary Sources
List of Figures
Figure 1. Anti-PD-1 Antibody Image
Figure 2. Global Anti-PD-1 Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Anti-PD-1 Antibody Market Size Share 2021 VS 2025 VS 2032
Figure 4. Monoclonal Image
Figure 5. Polyclonal Image
Figure 6. Global Anti-PD-1 Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Figure 7. Global Anti-PD-1 Antibody Market Size Share 2021 VS 2025 VS 2032
Figure 8. IHC-P Image
Figure 9. ICC/IF Image
Figure 10. ELISA Image
Figure 11. Flow Cytometry Image
Figure 12. WB Image
Figure 13. Global Anti-PD-1 Antibody Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 14. Global Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million)
Figure 15. Global Anti-PD-1 Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 16. Global Anti-PD-1 Antibody Revenue Market Share by Region: 2025 Versus 2032
Figure 17. Global Anti-PD-1 Antibody Revenue Market Share by Region (2021-2032)
Figure 18. Global Anti-PD-1 Antibody Sales (2021-2032) & (kg)
Figure 19. Global Anti-PD-1 Antibody Sales by Region: 2021 VS 2025 VS 2032 (kg)
Figure 20. Global Anti-PD-1 Antibody Sales Market Share by Region (2021-2032)
Figure 21. US & Canada & Mexico Anti-PD-1 Antibody Sales YoY (2021-2032) & (kg)
Figure 22. Europe Anti-PD-1 Antibody Sales YoY (2021-2032) & (kg)
Figure 23. China Anti-PD-1 Antibody Sales YoY (2021-2032) & (kg)
Figure 24. Asia (Excluding China) Anti-PD-1 Antibody Sales YoY (2021-2032) & (kg)
Figure 25. South America, Middle East and Africa Anti-PD-1 Antibody Sales YoY (2021-2032) & (kg)
Figure 26. Global Anti-PD-1 Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025
Figure 27. Global Anti-PD-1 Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025
Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 29. Global Anti-PD-1 Antibody Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 30. Global Anti-PD-1 Antibody Revenue Market Share by Type 2021 VS 2025 VS 2032
Figure 31. Global Anti-PD-1 Antibody Revenue Market Share by Type (2021-2032)
Figure 32. Global Anti-PD-1 Antibody Sales by Type (2021 VS 2025 VS 2032) & (kg)
Figure 33. Global Anti-PD-1 Antibody Sales Market Share by Type 2021 VS 2025 VS 2032
Figure 34. Global Anti-PD-1 Antibody Sales Market Share by Type (2021-2032)
Figure 35. Global Anti-PD-1 Antibody Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 36. Global Anti-PD-1 Antibody Revenue Market Share by Application 2021 VS 2025 VS 2032
Figure 37. Global Anti-PD-1 Antibody Revenue Market Share by Application (2021-2032)
Figure 38. Global Anti-PD-1 Antibody Sales by Application (2021 VS 2025 VS 2032) & (kg)
Figure 39. Global Anti-PD-1 Antibody Sales Market Share by Application 2021 VS 2025 VS 2032
Figure 40. Global Anti-PD-1 Antibody Sales Market Share by Application (2021-2032)
Figure 41. North America Anti-PD-1 Antibody Revenue Share by Type (2021-2032)
Figure 42. North America Anti-PD-1 Antibody Sales Share by Type (2021-2032)
Figure 43. North America Anti-PD-1 Antibody Revenue Share by Application (2021-2032)
Figure 44. North America Anti-PD-1 Antibody Sales Share by Application (2021-2032)
Figure 45. North America Anti-PD-1 Antibody Revenue Share by Country (2021-2032)
Figure 46. North America Anti-PD-1 Antibody Sales Share by Country (2021-2032)
Figure 47. Europe Anti-PD-1 Antibody Revenue Share by Type (2021-2032)
Figure 48. Europe Anti-PD-1 Antibody Sales Share by Type (2021-2032)
Figure 49. Europe Anti-PD-1 Antibody Revenue Share by Application (2021-2032)
Figure 50. Europe Anti-PD-1 Antibody Sales Share by Application (2021-2032)
Figure 51. Europe Anti-PD-1 Antibody Revenue Share by Country (2021-2032)
Figure 52. Europe Anti-PD-1 Antibody Sales Share by Country (2021-2032)
Figure 53. China Anti-PD-1 Antibody Revenue Share by Type (2021-2032)
Figure 54. China Anti-PD-1 Antibody Sales Share by Type (2021-2032)
Figure 55. China Anti-PD-1 Antibody Revenue Share by Application (2021-2032)
Figure 56. China Anti-PD-1 Antibody Sales Share by Application (2021-2032)
Figure 57. Asia Anti-PD-1 Antibody Revenue Share by Type (2021-2032)
Figure 58. Asia Anti-PD-1 Antibody Sales Share by Type (2021-2032)
Figure 59. Asia Anti-PD-1 Antibody Revenue Share by Application (2021-2032)
Figure 60. Asia Anti-PD-1 Antibody Sales Share by Application (2021-2032)
Figure 61. Asia Anti-PD-1 Antibody Revenue Share by Country (2021-2032)
Figure 62. Asia Anti-PD-1 Antibody Sales Share by Country (2021-2032)
Figure 63. SAMEA Anti-PD-1 Antibody Revenue Share by Type (2021-2032)
Figure 64. SAMEA Anti-PD-1 Antibody Sales Share by Type (2021-2032)
Figure 65. SAMEA Anti-PD-1 Antibody Revenue Share by Application (2021-2032)
Figure 66. SAMEA Anti-PD-1 Antibody Sales Share by Application (2021-2032)
Figure 67. SAMEA Anti-PD-1 Antibody Revenue Share by Country (2021-2032)
Figure 68. SAMEA Anti-PD-1 Antibody Sales Share by Country (2021-2032)
Figure 69. Anti-PD-1 Antibody Value Chain
Figure 70. Manufacturing Cost Structure
Figure 71. Anti-PD-1 Antibody Production Mode & Process
Figure 72. Direct Comparison with Distribution Share
Figure 73. Distributors Profiles
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
Scope & coverage.
Types
- Monoclonal
- Polyclonal
Applications
- IHC-P
- ICC/IF
- ELISA
- Flow Cytometry
- WB
Companies covered
- 3SBio Inc
- Thermo Fisher
- Novartis
- Merck
- Lilly
- Sino Biological Inc
- Bristol-Myers Squibb (BMS)
- Abcam
- Abbvie
- TG Therapeutics, Inc
- Ono Pharmaceutical Co., Ltd
- InvivoGen
- Chugai Pharmaceutical Co., Ltd
- BioVision Inc
- Bio X Cell
- BeiGene
- Arcus Biosciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Anti-PD-1 Antibody Market by Type
- 1.2.1 Global Anti-PD-1 Antibody Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Monoclonal
- 1.2.3 Polyclonal
- 1.3 Anti-PD-1 Antibody Market by Application
- 1.3.1 Global Anti-PD-1 Antibody Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 IHC-P
- 1.3.3 ICC/IF
- 1.3.4 ELISA
- 1.3.5 Flow Cytometry
- 1.3.6 WB
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Anti-PD-1 Antibody Market Dynamics
- 2.1 Anti-PD-1 Antibody Industry Trends
- 2.2 Anti-PD-1 Antibody Industry Drivers
- 2.3 Anti-PD-1 Antibody Industry Opportunities and Challenges
- 2.4 Anti-PD-1 Antibody Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Anti-PD-1 Antibody Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Anti-PD-1 Antibody Revenue by Region
- 3.2.1 Global Anti-PD-1 Antibody Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Anti-PD-1 Antibody Revenue by Region (2021-2026)
- 3.2.3 Global Anti-PD-1 Antibody Revenue by Region (2027-2032)
- 3.2.4 Global Anti-PD-1 Antibody Revenue Market Share by Region (2021-2032)
- 3.3 Global Anti-PD-1 Antibody Sales Estimates and Forecasts 2021-2032
- 3.4 Global Anti-PD-1 Antibody Sales by Region
- 3.4.1 Global Anti-PD-1 Antibody Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Anti-PD-1 Antibody Sales by Region (2021-2026)
- 3.4.3 Global Anti-PD-1 Antibody Sales by Region (2027-2032)
- 3.4.4 Global Anti-PD-1 Antibody Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Anti-PD-1 Antibody Revenue by Manufacturers
- 4.1.1 Global Anti-PD-1 Antibody Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Anti-PD-1 Antibody Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Anti-PD-1 Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Anti-PD-1 Antibody Sales by Manufacturers
- 4.2.1 Global Anti-PD-1 Antibody Sales by Manufacturers (2021-2026)
- 4.2.2 Global Anti-PD-1 Antibody Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Anti-PD-1 Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Anti-PD-1 Antibody Sales Price by Manufacturers (2021-2026)
- 4.4 Global Anti-PD-1 Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Anti-PD-1 Antibody Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Anti-PD-1 Antibody Manufacturers, Product Type & Application
- 4.7 Global Anti-PD-1 Antibody Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Anti-PD-1 Antibody Market CR5 and HHI
- 4.8.2 2025 Anti-PD-1 Antibody Tier 1, Tier 2, and Tier 3
5 Anti-PD-1 Antibody Market by Type
- 5.1 Global Anti-PD-1 Antibody Revenue by Type
- 5.1.1 Global Anti-PD-1 Antibody Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Anti-PD-1 Antibody Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Anti-PD-1 Antibody Revenue Market Share by Type (2021-2032)
- 5.2 Global Anti-PD-1 Antibody Sales by Type
- 5.2.1 Global Anti-PD-1 Antibody Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-PD-1 Antibody Sales by Type (2021-2032) & (kg)
- 5.2.3 Global Anti-PD-1 Antibody Sales Market Share by Type (2021-2032)
- 5.3 Global Anti-PD-1 Antibody Price by Type
6 Anti-PD-1 Antibody Market by Application
- 6.1 Global Anti-PD-1 Antibody Revenue by Application
- 6.1.1 Global Anti-PD-1 Antibody Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Anti-PD-1 Antibody Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Anti-PD-1 Antibody Revenue Market Share by Application (2021-2032)
- 6.2 Global Anti-PD-1 Antibody Sales by Application
- 6.2.1 Global Anti-PD-1 Antibody Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Anti-PD-1 Antibody Sales by Application (2021-2032) & (kg)
- 6.2.3 Global Anti-PD-1 Antibody Sales Market Share by Application (2021-2032)
- 6.3 Global Anti-PD-1 Antibody Price by Application
7 Company Profiles
- 7.1 3SBio Inc
- 7.1.1 3SBio Inc Company Information
- 7.1.2 3SBio Inc Business Overview
- 7.1.3 3SBio Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 3SBio Inc Anti-PD-1 Antibody Product Portfolio
- 7.1.5 3SBio Inc Recent Developments
- 7.2 Thermo Fisher
- 7.2.1 Thermo Fisher Company Information
- 7.2.2 Thermo Fisher Business Overview
- 7.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Thermo Fisher Anti-PD-1 Antibody Product Portfolio
- 7.2.5 Thermo Fisher Recent Developments
- 7.3 Novartis
- 7.3.1 Novartis Company Information
- 7.3.2 Novartis Business Overview
- 7.3.3 Novartis Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Novartis Anti-PD-1 Antibody Product Portfolio
- 7.3.5 Novartis Recent Developments
- 7.4 Merck
- 7.4.1 Merck Company Information
- 7.4.2 Merck Business Overview
- 7.4.3 Merck Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Merck Anti-PD-1 Antibody Product Portfolio
- 7.4.5 Merck Recent Developments
- 7.5 Lilly
- 7.5.1 Lilly Company Information
- 7.5.2 Lilly Business Overview
- 7.5.3 Lilly Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Lilly Anti-PD-1 Antibody Product Portfolio
- 7.5.5 Lilly Recent Developments
- 7.6 Sino Biological Inc
- 7.6.1 Sino Biological Inc Company Information
- 7.6.2 Sino Biological Inc Business Overview
- 7.6.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Sino Biological Inc Anti-PD-1 Antibody Product Portfolio
- 7.6.5 Sino Biological Inc Recent Developments
- 7.7 Bristol-Myers Squibb (BMS)
- 7.7.1 Bristol-Myers Squibb (BMS) Company Information
- 7.7.2 Bristol-Myers Squibb (BMS) Business Overview
- 7.7.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Portfolio
- 7.7.5 Bristol-Myers Squibb (BMS) Recent Developments
- 7.8 Abcam
- 7.8.1 Abcam Company Information
- 7.8.2 Abcam Business Overview
- 7.8.3 Abcam Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Abcam Anti-PD-1 Antibody Product Portfolio
- 7.8.5 Abcam Recent Developments
- 7.9 Abbvie
- 7.9.1 Abbvie Company Information
- 7.9.2 Abbvie Business Overview
- 7.9.3 Abbvie Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Abbvie Anti-PD-1 Antibody Product Portfolio
- 7.9.5 Abbvie Recent Developments
- 7.10 TG Therapeutics, Inc
- 7.10.1 TG Therapeutics, Inc Company Information
- 7.10.2 TG Therapeutics, Inc Business Overview
- 7.10.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 TG Therapeutics, Inc Anti-PD-1 Antibody Product Portfolio
- 7.10.5 TG Therapeutics, Inc Recent Developments
- 7.11 Ono Pharmaceutical Co., Ltd
- 7.11.1 Ono Pharmaceutical Co., Ltd Company Information
- 7.11.2 Ono Pharmaceutical Co., Ltd Business Overview
- 7.11.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
- 7.11.5 Ono Pharmaceutical Co., Ltd Recent Developments
- 7.12 InvivoGen
- 7.12.1 InvivoGen Company Information
- 7.12.2 InvivoGen Business Overview
- 7.12.3 InvivoGen Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 InvivoGen Anti-PD-1 Antibody Product Portfolio
- 7.12.5 InvivoGen Recent Developments
- 7.13 Chugai Pharmaceutical Co., Ltd
- 7.13.1 Chugai Pharmaceutical Co., Ltd Company Information
- 7.13.2 Chugai Pharmaceutical Co., Ltd Business Overview
- 7.13.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
- 7.13.5 Chugai Pharmaceutical Co., Ltd Recent Developments
- 7.14 BioVision Inc
- 7.14.1 BioVision Inc Company Information
- 7.14.2 BioVision Inc Business Overview
- 7.14.3 BioVision Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 BioVision Inc Anti-PD-1 Antibody Product Portfolio
- 7.14.5 BioVision Inc Recent Developments
- 7.15 Bio X Cell
- 7.15.1 Bio X Cell Company Information
- 7.15.2 Bio X Cell Business Overview
- 7.15.3 Bio X Cell Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Bio X Cell Anti-PD-1 Antibody Product Portfolio
- 7.15.5 Bio X Cell Recent Developments
- 7.16 BeiGene
- 7.16.1 BeiGene Company Information
- 7.16.2 BeiGene Business Overview
- 7.16.3 BeiGene Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.16.4 BeiGene Anti-PD-1 Antibody Product Portfolio
- 7.16.5 BeiGene Recent Developments
- 7.17 Arcus Biosciences
- 7.17.1 Arcus Biosciences Company Information
- 7.17.2 Arcus Biosciences Business Overview
- 7.17.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.17.4 Arcus Biosciences Anti-PD-1 Antibody Product Portfolio
- 7.17.5 Arcus Biosciences Recent Developments
8 North America
- 8.1 North America Anti-PD-1 Antibody Market Size by Type
- 8.1.1 North America Anti-PD-1 Antibody Revenue by Type (2021-2032)
- 8.1.2 North America Anti-PD-1 Antibody Sales by Type (2021-2032)
- 8.1.3 North America Anti-PD-1 Antibody Price by Type (2021-2032)
- 8.2 North America Anti-PD-1 Antibody Market Size by Application
- 8.2.1 North America Anti-PD-1 Antibody Revenue by Application (2021-2032)
- 8.2.2 North America Anti-PD-1 Antibody Sales by Application (2021-2032)
- 8.2.3 North America Anti-PD-1 Antibody Price by Application (2021-2032)
- 8.3 North America Anti-PD-1 Antibody Market Size by Country
- 8.3.1 North America Anti-PD-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Anti-PD-1 Antibody Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Anti-PD-1 Antibody Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Anti-PD-1 Antibody Market Size by Type
- 9.1.1 Europe Anti-PD-1 Antibody Revenue by Type (2021-2032)
- 9.1.2 Europe Anti-PD-1 Antibody Sales by Type (2021-2032)
- 9.1.3 Europe Anti-PD-1 Antibody Price by Type (2021-2032)
- 9.2 Europe Anti-PD-1 Antibody Market Size by Application
- 9.2.1 Europe Anti-PD-1 Antibody Revenue by Application (2021-2032)
- 9.2.2 Europe Anti-PD-1 Antibody Sales by Application (2021-2032)
- 9.2.3 Europe Anti-PD-1 Antibody Price by Application (2021-2032)
- 9.3 Europe Anti-PD-1 Antibody Market Size by Country
- 9.3.1 Europe Anti-PD-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Anti-PD-1 Antibody Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Anti-PD-1 Antibody Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Anti-PD-1 Antibody Market Size by Type
- 10.1.1 China Anti-PD-1 Antibody Revenue by Type (2021-2032)
- 10.1.2 China Anti-PD-1 Antibody Sales by Type (2021-2032)
- 10.1.3 China Anti-PD-1 Antibody Price by Type (2021-2032)
- 10.2 China Anti-PD-1 Antibody Market Size by Application
- 10.2.1 China Anti-PD-1 Antibody Revenue by Application (2021-2032)
- 10.2.2 China Anti-PD-1 Antibody Sales by Application (2021-2032)
- 10.2.3 China Anti-PD-1 Antibody Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Anti-PD-1 Antibody Market Size by Type
- 11.1.1 Asia Anti-PD-1 Antibody Revenue by Type (2021-2032)
- 11.1.2 Asia Anti-PD-1 Antibody Sales by Type (2021-2032)
- 11.1.3 Asia Anti-PD-1 Antibody Price by Type (2021-2032)
- 11.2 Asia Anti-PD-1 Antibody Market Size by Application
- 11.2.1 Asia Anti-PD-1 Antibody Revenue by Application (2021-2032)
- 11.2.2 Asia Anti-PD-1 Antibody Sales by Application (2021-2032)
- 11.2.3 Asia Anti-PD-1 Antibody Price by Application (2021-2032)
- 11.3 Asia Anti-PD-1 Antibody Market Size by Country
- 11.3.1 Asia Anti-PD-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Anti-PD-1 Antibody Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Anti-PD-1 Antibody Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Anti-PD-1 Antibody Market Size by Type
- 12.1.1 SAMEA Anti-PD-1 Antibody Revenue by Type (2021-2032)
- 12.1.2 SAMEA Anti-PD-1 Antibody Sales by Type (2021-2032)
- 12.1.3 SAMEA Anti-PD-1 Antibody Price by Type (2021-2032)
- 12.2 SAMEA Anti-PD-1 Antibody Market Size by Application
- 12.2.1 SAMEA Anti-PD-1 Antibody Revenue by Application (2021-2032)
- 12.2.2 SAMEA Anti-PD-1 Antibody Sales by Application (2021-2032)
- 12.2.3 SAMEA Anti-PD-1 Antibody Price by Application (2021-2032)
- 12.3 SAMEA Anti-PD-1 Antibody Market Size by Country
- 12.3.1 SAMEA Anti-PD-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Anti-PD-1 Antibody Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Anti-PD-1 Antibody Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Anti-PD-1 Antibody Value Chain Analysis
- 13.1.1 Anti-PD-1 Antibody Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Anti-PD-1 Antibody Production Mode & Process
- 13.2 Anti-PD-1 Antibody Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Anti-PD-1 Antibody Distributors
- 13.2.3 Anti-PD-1 Antibody Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst